Results 11 to 20 of about 651,238 (350)

Association of C-type lectin-like receptor 2 and galectin-1 with portal vein system thrombosis in HBV-related liver cirrhosis

open access: yesFrontiers in Medicine, 2023
Background and aimsHepatitis B virus (HBV) infection is the most common cause of liver cirrhosis. Portal venous system thrombosis (PVST) is a major complication of liver cirrhosis.
Yiyan Zhang   +12 more
doaj   +1 more source

Identification of novel non-HFE mutations in Chinese patients with hereditary hemochromatosis

open access: yesOrphanet Journal of Rare Diseases, 2022
Backgrounds Hereditary hemochromatosis (HH) is mainly caused by homozygous p.C282Y mutations in HFE in the Caucasians. We recently reported non-HFE mutations constitute the major cause of HH in Chinese.
Wei Zhang   +17 more
doaj   +1 more source

HCC Surveillance Improves Early Detection, Curative Treatment Receipt, and Survival in Patients with Cirrhosis: A Systematic Review and Meta-Analysis.

open access: yesJournal of Hepatology, 2022
BACKGROUND There is controversy regarding the overall value of hepatocellular carcinoma (HCC) surveillance in patients with cirrhosis given a lack of randomized controlled data. To address this issue, we conducted a systematic review and meta-analysis of
A. Singal   +11 more
semanticscholar   +1 more source

Serum Mac-2-binding protein glycosylation isomer predicts esophagogastric varices in cirrhotic patients with chronic hepatitis C virus infection treated with IFN-free direct-acting antiviral agent: M2BPGi levels predict varices in SVR patients

open access: yesAnnals of Hepatology, 2020
Introduction and objectives: We examined whether Mac-2-binding protein glycosylation isomer (M2BPGi) levels could be a predictive marker for the presence of esophagogastric varices (EGV) in cirrhotic patients after hepatitis C virus (HCV) eradication ...
Kanako Kikukawa   +12 more
doaj   +1 more source

Correlation of genotype and phenotype in 32 patients with hereditary hemochromatosis in China

open access: yesOrphanet Journal of Rare Diseases, 2021
Background Hereditary hemochromatosis (HH) is widely recognized and clinical manifestations of hemochromatosis-related (HFE-related) HH is well studied in European populations.
Liyan Wu   +17 more
doaj   +1 more source

Evidence-based clinical practice guidelines for Liver Cirrhosis 2020

open access: yesJournal of gastroenterology, 2021
The first edition of the clinical practice guidelines for liver cirrhosis was published in 2010, and the second edition was published in 2015 by the Japanese Society of Gastroenterology (JSGE).
H. Yoshiji   +20 more
semanticscholar   +1 more source

Association of thromboelastography profile with severity of liver cirrhosis and portal venous system thrombosis

open access: yesBMC Gastroenterology, 2021
Background and aim Hemostasis profile is often complicated in liver cirrhosis. Thromboelastography is a global viscoelastic test recommended by the current practice guideline and consensus.
Yanglan He   +8 more
doaj   +1 more source

Sarcopenia and frailty in decompensated cirrhosis.

open access: yesJournal of Hepatology, 2021
In patients with decompensated cirrhosis, sarcopenia and frailty are prevalent. Although several definitions exist for these terms, in the field of hepatology, sarcopenia has commonly been defined as loss of muscle mass, and frailty has been broadly ...
P. Tandon   +4 more
semanticscholar   +1 more source

Clinical characteristics and therapeutic response of immunoglobulin G4-related disease: a retrospective study of 127 Chinese patients

open access: yesOrphanet Journal of Rare Diseases, 2022
Background and aims Immunoglobulin G4-related disease (IgG4-RD) is a multisystem fibroinflammatory condition. The aim of the present study was to characterize the clinical features and therapeutic response of patients with IgG4-RD and identify risk ...
Wen An   +16 more
doaj   +1 more source

Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis.

open access: yesClinical Gastroenterology and Hepatology, 2020
BACKGROUND Accurate estimates for the contemporary burden of chronic liver disease (CLD) are vital for setting clinical, research, and policy priorities.
A. Moon, A. Singal, E. Tapper
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy